ImageneBio, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- ImageneBio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-12-31 was 0.00 shares.
- ImageneBio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-09-30 was 1.76K shares.
- ImageneBio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-06-30 was 0.00 shares.
- ImageneBio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for the quarter ending 2025-03-31 was 0.00 shares.
- ImageneBio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2025 was 1.76K shares.
- ImageneBio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2024 was 0.00 shares, a 100.00% decline from fiscal 2023.
- ImageneBio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2023 was 34.03K shares, a 87.95% decline from fiscal 2022.
- ImageneBio, Inc. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 282.46K shares, a 31.26% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | 1.76K shares 10-K · filed 2026-03-10 |
| 2025-09-30 | 1.76K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | 1.76K shares derived: sum of 4 quarters · filed 2025-11-12 |
| 2025-06-30 | 0.00 shares 10-Q · filed 2025-07-24 | 0.00 shares derived: sum of 4 quarters · filed 2025-07-24 |
| 2025-03-31 | 0.00 shares 10-Q · filed 2025-05-08 | 0.00 shares derived: sum of 4 quarters · filed 2025-07-24 |
| 2024-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | 0.00 shares 10-K · filed 2025-03-06 |
| 2024-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | |
| 2024-06-30 | 0.00 shares 10-Q · filed 2025-07-24 | |
| 2024-03-31 | 0.00 shares 10-Q · filed 2025-05-08 | |
| 2023-12-31 | 34.03K shares 10-K · filed 2024-03-12 | |
| 2023-03-31 | 0.00 shares 10-Q · filed 2024-05-13 | 147.96K shares derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | 282.46K shares 10-K · filed 2023-03-14 |
| 2022-09-30 | 5.52K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-07 | 379.70K shares derived: sum of 4 quarters · filed 2022-11-07 |
| 2022-06-30 | 142.44K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 392.86K shares derived: sum of 4 quarters · filed 2022-08-11 |
| 2022-03-31 | 134.50K shares 10-Q · filed 2022-05-12 | 258.29K shares derived: sum of 4 quarters · filed 2022-05-12 |
| 2021-12-31 | 97.24K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | 215.19K shares 10-K · filed 2022-03-17 |
| 2021-09-30 | 18.68K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | |
| 2021-06-30 | 7.88K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | |
| 2021-03-31 | 91.39K shares 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |